Digital Edition: MedTech Strategist December 2023

article image
ARTICLE SUMMARY:

BD's CTO Beth McCombs discusses her approach to driving innovation at the global medtech giant; part one of our survey on the $6 billion venous device market; Enovis makes a roll-up strategy in orthopedics work; the first renal denervation devices finally hit the US market; with Larimar buy, J&J executes on its goal of upping its mix of high-growth products. Plus profiles of Arsenal Medical and Ciliatech.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: